Pharmaceutical

Pluri launches manufacturing division as cell therapy pipeline progresses

In an interview with Pharmaceutical Technology, Pluri’s CEO discussed its recent launch as a CDMO as well as its cell therapy pipeline.

Apr 9, 2024 - 00:00
Pluri launches manufacturing division as cell therapy pipeline progresses
In an interview with Pharmaceutical Technology, Pluri’s CEO discussed its recent launch as a CDMO as well as its cell therapy pipeline.
Read the original article

Tags:

Previous Article

FDA accepts Shorla’s oral liquid leukaemia drug NDA

Next Article

J&J and Legend’s Carvykti scores early line approval for MM by FDA

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Vertex non-opioid drug reduces chronic nerve pain in mid-stage study

STAT+: Vertex non-opioid drug reduces chronic nerve pai...

Dec 13, 2023

STAT+: Wegovy is usually taken indefinitely. Amgen wants a version that can be tapered down

STAT+: Wegovy is usually taken indefinitely. Amgen want...

Feb 5, 2024

Nxera Pharma and Antiverse to design antibodies targeting GPCRs

Nxera Pharma and Antiverse to design antibodies targeti...

Nov 7, 2024